Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical Trials
From MaRDI portal
Publication:5254712
DOI10.1198/jasa.2009.ap08425zbMath1388.62008OpenAlexW2000705046MaRDI QIDQ5254712
Publication date: 10 June 2015
Published in: Journal of the American Statistical Association (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1198/jasa.2009.ap08425
Applications of statistics to biology and medical sciences; meta analysis (62P10) Optimal statistical designs (62K05) Bayesian problems; characterization of Bayes procedures (62C10) Sequential statistical design (62L05)
Related Items
Novel Bayesian Adaptive Designs and Their Applications in Cancer Clinical Trials ⋮ A new design of the continual reassessment method ⋮ Impact of different model structure and prior distribution in continual reassessment method ⋮ PA‐CRM: A continuous reassessment method for pediatric phase I oncology trials with concurrent adult trials ⋮ Bayesian Model Averaging: A Systematic Review and Conceptual Classification ⋮ A continual reassessment method without undue risk of toxicity ⋮ Continual reassessment and related dose-finding designs ⋮ Bayesian data augmentation dose finding with continual reassessment method and delayed toxicity ⋮ Adaptive clinical trial designs for phase I cancer studies ⋮ A Phase I Bayesian Adaptive Design to Simultaneously Optimize Dose and Schedule Assignments Both Between and Within Patients
